Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Weight management is influenced by many factors, including medical history, current medications, lifestyle, existing health conditions, and long-term health goals
NHS access to these medicines is subject to NICE eligibility criteria, which typically include BMI thresholds, the presence of weight-related comorbidities, and involvement of a specialist weight management service
Rising diabetes prevalence and expanding healthcare infrastructure are driving demand for GLP-1 drugs across pharmaceutical companies, healthcare providers, and digital health platforms throughout major Chinese healthcare centers
Retatrutide is a triple agonist acting at GIP, GLP-1, and glucagon receptors, whereas semaglutide targets GLP-1 alone [4][3]
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
